Dobutamine-atropine stress echocardiography and clinical data for predicting late cardiac events in patients with suspected coronary artery disease.

PURPOSE To compare the relative value of clinical variables with dobutamine-atropine stress echocardiography to predict cardiac events during long-term follow-up. Dobutamine stress echocardiography is increasingly used for the detection of coronary artery disease, but little is known of its prognostic value. PATIENTS AND METHODS A total of 430 patients (310 men; mean age 61 years, range 22 to 90) were enrolled in the study. Patients were referred for chest pain complaints and were unable to perform an adequate exercise stress test. All patients underwent dobutamine-atropine stress test (incremental dobutamine infusion: 10 to 40 micrograms/kg/minute, continued with atropine 0.25 to 1 mg intravenously if necessary to achieve 85% of the age predicted maximal heart rate, without symptoms or signs of ischemia) and clinical cardiac evaluation. Follow-up was 17 +/- 5 months, with a minimum of 6 months; 3 patients were lost to follow-up. Cardiac events were defined as cardiac death, nonfatal myocardial infarction, and coronary revascularization. RESULTS Seventy-nine cardiac events occurred in 76 patients: cardiac death (n = 11), nonfatal myocardial infarction (n = 18), and coronary revascularization (n = 50). By multivariate regression analysis, the prognostic value of the stress test in addition to common clinical variables was assessed. (1) Cardiac death was predicted by age greater than 70 years (odds ratio 5.6, 1.5 to 20) or new wall motion abnormalities in a study that is normal at rest (odds ratio 4.1, 1.1 to 15). (2) Death or myocardial infarction was predicted by a history of myocardial infarction (odds ratio 4.8, 1.8 to 13) or age greater than 70 years (odds ratio 2.3, 1.1 to 5.4), and the stress test outcome provided no additional information. (3) If all events were combined, only stress test results were prognostic: new wall motion abnormalities in a study that is normal at rest (odds ratio 3.1, 1.9 to 5.1), wall motion abnormalities at rest (wall motion score at rest > or = 1.12) (odds ratio 2.5, 1.4 to 4.0), or any new wall motion abnormalities during stress (odds ratio 2.0, 1.4 to 3.8). The positive predictive value of any new wall motion abnormality during stress for all late cardiac events was 25% (95% confidence interval [CI] 19 to 31) with a negative predictive value of 87% (95% CI 83 to 91). CONCLUSION In a large cohort of unselected patients with chest pain syndromes, new wall motion abnormalities induced by dobutamine provide additional information for late cardiac events, independent of clinical variables.

[1]  A. Salustri,et al.  Exercise echocardiography and technetium-99m MIBI single-photon emission computed tomography in the detection of coronary artery disease. , 1991, The American journal of cardiology.

[2]  R. W. Brower,et al.  Prediction of mortality during the first year after acute myocardial infarction from clinical variables and stress test at hospital discharge. , 1985, The American journal of cardiology.

[3]  N. Hertzer,et al.  Coronary Artery Disease in Peripheral Vascular Patients: A Classification of 1000 Coronary Angiograms and Results of Surgical Management , 1984, Annals of surgery.

[4]  E. Picano,et al.  Prognostic importance of dipyridamole-echocardiography test in coronary artery disease. , 1989, Circulation.

[5]  A. Salustri,et al.  Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. , 1992, The American journal of cardiology.

[6]  A. Salustri,et al.  Reproducibility of the Dobutamine‐Atropine Echocardiography Stress Test , 1993 .

[7]  T. Marwick,et al.  Selection of the Optimal Nonexercise Stress for the Evaluation of Ischemic Regional Myocardial Dysfunction and Malperfusion Comparison of Dobutamine and Adenosine Using Echocardiography and 99mTc‐MIBI Single Photon Emission Computed Tomography , 1993, Circulation.

[8]  J R Roelandt,et al.  Dobutamine Stress Echocardiography for Assessment of Perioperative Cardiac Risk in Patients Undergoing Major Vascular Surgery , 1993, Circulation.

[9]  T. Cripps,et al.  The dobutamine stress test as an alternative to exercise testing after acute myocardial infarction. , 1988, British heart journal.

[10]  C S Kim,et al.  Dobutamine digital echocardiography for detecting coronary artery disease. , 1991, The American journal of cardiology.

[11]  J. Roelandt,et al.  Akinesis becoming dyskinesis during high-dose dobutamine stress echocardiography: a marker of myocardial ischemia or a mechanical phenomenon? , 1994, The American journal of cardiology.

[12]  B. Chaitman,et al.  Perioperative and long-term prognostic value of intravenous dipyridamole thallium scintigraphy in patients with peripheral vascular disease. , 1990, American heart journal.

[13]  E. Rose,et al.  Prognostic value of noninvasive cardiac tests in the assessment of patients with peripheral vascular disease. , 1993, The American journal of cardiology.

[14]  G. Schuler,et al.  Regular Physical Exercise and Low‐Fat Diet: Effects on Progression of Coronary Artery Disease , 1992, Circulation.

[15]  P. Rønnevik,et al.  Prognostic importance of predischarge exercise capacity for long-term mortality and non-fatal myocardial infarction in patients admitted for suspected acute myocardial infarction and treated with metoprolol. , 1992, European heart journal.

[16]  J B Seward,et al.  Standardized nomenclature and anatomic basis for regional tomographic analysis of the heart. , 1981, Mayo Clinic proceedings.

[17]  W. Armstrong,et al.  Accuracy of dobutamine stress echocardiography in detecting coronary artery disease. , 1992, The American journal of cardiology.

[18]  K. Brown Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age. , 1991, Circulation.

[19]  R. Hendel,et al.  Prognostic value of dipyridamole thallium scintigraphy for evaluation of ischemic heart disease. , 1990, Journal of the American College of Cardiology.

[20]  M. Bodenheimer,et al.  Prognostic significance from 10-year follow-up of a qualitatively normal planar exercise thallium test in suspected coronary artery disease. , 1993, The American journal of cardiology.

[21]  E. Cook,et al.  Long-term prognosis of myocardial ischemia detected by Holter monitoring in peripheral vascular disease. , 1990, The American journal of cardiology.

[22]  C. Oakley,et al.  Prognostic value of dobutamine echocardiography in patients with high pretest likelihood of coronary artery disease. , 1993, The American journal of cardiology.